{"id":"https://openalex.org/W2009794857","doi":"https://doi.org/10.1016/0065-2571(84)90014-1","title":"Biochemical pharmacology of the lipophilic antifolate, trimetrexate","display_name":"Biochemical pharmacology of the lipophilic antifolate, trimetrexate","alternate_titles":[],"publication_year":1984,"publication_date":"1984-01-01","ids":{"openalex":"https://openalex.org/W2009794857","doi":"https://doi.org/10.1016/0065-2571(84)90014-1","mag":"2009794857","pmid":"https://pubmed.ncbi.nlm.nih.gov/6236675"},"language":"en","primary_location":{"id":"doi:10.1016/0065-2571(84)90014-1","doi":"https://doi.org/10.1016/0065-2571(84)90014-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0065-2571(84)90014-1","pdf_url":null,"source":{"id":"https://openalex.org/S4210167908","display_name":"Advances in Enzyme Regulation","issn_l":"0065-2571","issn":["0065-2571","1873-2437"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320146","host_organization_name":"Pergamon Press","host_organization_lineage":["https://openalex.org/P4310320146"],"host_organization_lineage_names":["Pergamon Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Enzyme Regulation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2009794857"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079739797","display_name":"Robert Jackson","orcid":"https://orcid.org/0000-0002-8216-9277","observed_orcids":["https://orcid.org/0000-0002-8216-9277"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert C. Jackson","raw_affiliation_strings":["Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033059231","display_name":"David W. Fry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David W. Fry","raw_affiliation_strings":["Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083970959","display_name":"Theodore J. Boritzki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Theodore J. Boritzki","raw_affiliation_strings":["Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055702094","display_name":"Judith A. Besserer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Judith A. Besserer","raw_affiliation_strings":["Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110908562","display_name":"Wilbur R. Leopold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wilbur R. Leopold","raw_affiliation_strings":["Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032973371","display_name":"Bernard J. Sloan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernard J. Sloan","raw_affiliation_strings":["Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050902667","display_name":"Edward F. Elslager","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Edward F. Elslager","raw_affiliation_strings":["Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48106 USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5325,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.90167061,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"22","issue":null,"first_page":"187","last_page":"206"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.32690000534057617,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.32690000534057617,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10499","display_name":"Folate and B Vitamins Research","score":0.24789999425411224,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.12309999763965607,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trimetrexate","display_name":"trimetrexate","score":0.9800000190734863},{"id":"https://openalex.org/keywords/antifolate-drugs","display_name":"antifolate","score":0.8220000267028809},{"id":"https://openalex.org/keywords/dihydrofolate-reductase-inhibition","display_name":"dihydrofolate reductase inhibition","score":0.9240000247955322},{"id":"https://openalex.org/keywords/methotrexate-resistance","display_name":"methotrexate resistance","score":0.9760000109672546},{"id":"https://openalex.org/keywords/tetrahydrofolate","display_name":"tetrahydrofolate","score":0.7829999923706055},{"id":"https://openalex.org/keywords/nucleotide-pools","display_name":"nucleotide pools","score":0.6359999775886536},{"id":"https://openalex.org/keywords/purine-ribonucleotides","display_name":"purine ribonucleotides","score":0.7409999966621399},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.7749999761581421},{"id":"https://openalex.org/keywords/thymidine","display_name":"thymidine","score":0.8640000224113464},{"id":"https://openalex.org/keywords/hypoxanthine","display_name":"hypoxanthine","score":0.9380000233650208},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7580000162124634},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7630000114440918},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.8199999928474426},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.6940000057220459},{"id":"https://openalex.org/keywords/plasma-clearance","display_name":"plasma clearance","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C2781382166","wikidata":"https://www.wikidata.org/wiki/Q50573407","display_name":"Antifolate","level":4,"score":0.868797779083252},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5610109567642212},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.5477631688117981},{"id":"https://openalex.org/C2781320022","wikidata":"https://www.wikidata.org/wiki/Q417149","display_name":"Dihydrofolate reductase","level":3,"score":0.5381655693054199},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5043720006942749},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40623775124549866},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.38552600145339966},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38212570548057556},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.31376463174819946},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13735926151275635},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003857","descriptor_name":"Deoxyuridine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005492","descriptor_name":"Folic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007939","descriptor_name":"Leukemia L1210","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007939","descriptor_name":"Leukemia L1210","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008214","descriptor_name":"Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008815","descriptor_name":"Mice, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012265","descriptor_name":"Ribonucleotides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013936","descriptor_name":"Thymidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016597","descriptor_name":"Trimetrexate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046508","descriptor_name":"Culture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0065-2571(84)90014-1","doi":"https://doi.org/10.1016/0065-2571(84)90014-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0065-2571(84)90014-1","pdf_url":null,"source":{"id":"https://openalex.org/S4210167908","display_name":"Advances in Enzyme Regulation","issn_l":"0065-2571","issn":["0065-2571","1873-2437"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320146","host_organization_name":"Pergamon Press","host_organization_lineage":["https://openalex.org/P4310320146"],"host_organization_lineage_names":["Pergamon Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Enzyme Regulation","raw_type":"journal-article"},{"id":"pmid:6236675","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6236675","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in enzyme regulation","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W966789498","https://openalex.org/W1502933577","https://openalex.org/W1513241457","https://openalex.org/W1513881133","https://openalex.org/W1515361454","https://openalex.org/W1525999130","https://openalex.org/W1530463449","https://openalex.org/W1559420331","https://openalex.org/W1565483916","https://openalex.org/W1596355603","https://openalex.org/W1607093696","https://openalex.org/W1945538024","https://openalex.org/W1995376945","https://openalex.org/W2004849455","https://openalex.org/W2005725046","https://openalex.org/W2019113394","https://openalex.org/W2020397817","https://openalex.org/W2025444976","https://openalex.org/W2039785166","https://openalex.org/W2071377852","https://openalex.org/W2077451485","https://openalex.org/W2079867668","https://openalex.org/W2081623629","https://openalex.org/W2105689639","https://openalex.org/W2134091314","https://openalex.org/W2135222446","https://openalex.org/W2258942313","https://openalex.org/W2414435754","https://openalex.org/W2415535341"],"related_works":["https://openalex.org/W7100749191","https://openalex.org/W2412178722","https://openalex.org/W2271920406","https://openalex.org/W4236851990","https://openalex.org/W2066865033","https://openalex.org/W1975287422","https://openalex.org/W2004685064","https://openalex.org/W1993247492","https://openalex.org/W2073391464","https://openalex.org/W2152204995"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2009794857","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
